Dudediligence.

Rockwell Medical, Inc

RMTINASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$28.3MSep ’24$24.7MDec ’24$18.9MMar ’25$16.1MJun ’25$15.9MSep ’25$18.3MDec ’25$17.3MMar ’26$17.8MJun ’26
Net income, by quarter
$1.7MSep ’24−$756,000Dec ’24−$1.5MMar ’25−$1.5MJun ’25−$1.8MSep ’25−$554,000Dec ’25−$1.6MMar ’26−$1.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$61.9M$72.8M$83.6M$101.5M$69.3M
Gross profit−$2.4M$4.1M$8.7M$17.5M$11.7M
Operating income−$30.3M−$16.8M−$6.7M$608,000−$4.7M
Net income−$32.7M−$18.7M−$8.4M−$480,000−$5.3M
Operating cash flow−$33.5M−$16.9M−$9.4M$4.2M−$659,000
Free cash flownone on filenone on file−$9.7M$3.2M−$1.2M
Cash$13.3M$10.1M$9.0M$15.7M$10.7M
Debt$20.6M$9.2M$8.3M$8.5M$8.8M
Shares outstanding8.5M12.2M29.1M34.1M39.4M